IBD features MME and Briefing.com lists it in In Play this afternoon. My sense is the move of the last 2 days is driven by those with knowledge of the pending announcement. I think the enrollment increase will be significant, the premium increases will be somewhat larger than medical cost increases thus yielding a better medical loss ratio. The combination of more lives, higher premium per life, and lower loss ratio compute to significant earnings increase over most recent quarter much less year ago quarter. Unlikely that the analysts would have predicted the huge increase in enrollment caused by management mishaps at CareFirst (where its management had been focused on nothing more than a buyout by Wellpoint). This has "perfect storm" characteristics only every variable is positive. Does anyone else have verifiable numbers?